Tokyo Tape
Sign in
← Sumitomo Chemical

Quarterly report · Q1

4005.TEDINET S100RJX5
Period2023-04-01 → 2023-06-30
Filed2023-08-08
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥563.1bn2023-04-01 → 2023-06-30Cons.Revenue IFRS
Revenue¥2.90T2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥774.1bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Operating income−¥71.7bn2023-04-01 → 2023-06-30Cons.Operating profit loss IFRS
Operating income¥66.3bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Profit before tax−¥49.9bn2023-04-01 → 2023-06-30Cons.Profit loss before tax IFRS
Profit before tax¥231m2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥113.7bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Net income (owners)−¥33.2bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥7.0bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥70.0bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income−¥51.2bn2023-04-01 → 2023-06-30Cons.Profit loss IFRS
Net income−¥46.9bn2022-04-01 → 2023-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥85.1bn2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Total assets¥4.37Tat 2023-06-30Cons.Assets IFRS
Total assets¥4.17Tat 2023-03-31Cons.Assets IFRS
Total assets¥4.67Tat 2022-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥2.82Tat 2023-06-30Cons.Liabilities IFRS
Total liabilities¥2.68Tat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥1.55Tat 2023-06-30Cons.Equity IFRS
Net assets / equity¥1.49Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥1.86Tat 2022-06-30Cons.Equity IFRS
Net assets / equity¥1.70Tat 2022-03-31dCons.Equity IFRS
Equity (owners)¥1.22Tat 2023-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.17Tat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.34Tat 2022-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥323.1bnat 2023-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥305.8bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥498.6bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥365.4bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow−¥131.9bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥111.6bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥42.6bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥13.4bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥19.4bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow¥46.0bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥142.0bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥178.5bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥11.5bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-20.272023-04-01 → 2023-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥4.272022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥42.812022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥4.272022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
Equity ratio28.0%at 2023-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio28.1%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio28.8%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-06-30¥37.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-06-30¥17.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-06-30¥20.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-06-30¥2.4bn
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥27.9bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥27.9bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥4.4bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentrevenue2023-04-01 → 2023-06-30¥78.8bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentrevenue external2023-04-01 → 2023-06-30¥73.4bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥5.5bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentsegment profit2023-04-01 → 2023-06-30¥3.0bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue2023-04-01 → 2023-06-30¥193.7bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue external2023-04-01 → 2023-06-30¥192.4bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥1.4bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentsegment profit2023-04-01 → 2023-06-30−¥21.0bn
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentrevenue2023-04-01 → 2023-06-30¥103.5bn
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentrevenue external2023-04-01 → 2023-06-30¥102.7bn
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥762m
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentsegment profit2023-04-01 → 2023-06-30−¥7.0bn
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentrevenue2023-04-01 → 2023-06-30¥94.6bn
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentrevenue external2023-04-01 → 2023-06-30¥94.5bn
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥110m
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentsegment profit2023-04-01 → 2023-06-30¥6.7bn
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentrevenue2023-04-01 → 2023-06-30¥83.0bn
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentrevenue external2023-04-01 → 2023-06-30¥83.0bn
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥1m
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentsegment profit2023-04-01 → 2023-06-30−¥33.3bn
—segment totalrevenue2023-04-01 → 2023-06-30¥553.6bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥545.9bn
—segment totalrevenue intersegment2023-04-01 → 2023-06-30¥7.7bn
—segment totalsegment profit2023-04-01 → 2023-06-30−¥51.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥31.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥14.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥17.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30¥3.3bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥24.8bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥24.8bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥7.5bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentrevenue2022-04-01 → 2022-06-30¥91.3bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentrevenue external2022-04-01 → 2022-06-30¥86.4bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥4.8bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentsegment profit2022-04-01 → 2022-06-30¥6.6bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue2022-04-01 → 2022-06-30¥240.0bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue external2022-04-01 → 2022-06-30¥238.6bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥1.5bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentsegment profit2022-04-01 → 2022-06-30¥10.0bn
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentrevenue2022-04-01 → 2022-06-30¥153.5bn
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentrevenue external2022-04-01 → 2022-06-30¥152.6bn
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥945m
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentsegment profit2022-04-01 → 2022-06-30¥21.9bn
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentrevenue2022-04-01 → 2022-06-30¥114.8bn
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentrevenue external2022-04-01 → 2022-06-30¥114.7bn
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥116m
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentsegment profit2022-04-01 → 2022-06-30¥15.8bn
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentrevenue2022-04-01 → 2022-06-30¥167.7bn
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentrevenue external2022-04-01 → 2022-06-30¥167.7bn
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥6m
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentsegment profit2022-04-01 → 2022-06-30¥14.1bn
—segment totalrevenue2022-04-01 → 2022-06-30¥767.3bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥759.9bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥7.4bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥68.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 840
ItemContextValueUnit
Transactions with non controlling interests ss IFRSCurrentYTDDuration_jpcrp040300-q1r_E00752-000OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember－JPY
Transactions with non controlling interests ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember－JPY
Transactions with non controlling interests ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember－JPY
Transactions with non controlling interests ss IFRSCurrentYTDDuration－JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-5366000000JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_jpcrp040300-q1r_E00752-000OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration－JPY
Other ss IFRSCurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Other ss IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Other ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Other ss IFRSCurrentYTDDuration_jpcrp040300-q1r_E00752-000OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember－JPY
Other ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember－JPY
Other ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember－JPY
Other ss IFRSCurrentYTDDuration－JPY
Total transactions with owners IFRSCurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Total transactions with owners IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Total transactions with owners IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-5366000000JPY
Total transactions with owners IFRSCurrentYTDDuration_jpcrp040300-q1r_E00752-000OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember-349000000JPY
Total transactions with owners IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-9813000000JPY
Total transactions with owners IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-3934000000JPY
Total transactions with owners IFRSCurrentYTDDuration-13747000000JPY
Equity IFRSCurrentQuarterInstant_EffectivePortionOfCashFlowHedgesIFRSMember330000000JPY
Equity IFRSCurrentQuarterInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember190482000000JPY
Equity IFRSCurrentQuarterInstant_OtherComponentsOfEquityIFRSMember289039000000JPY
Equity IFRSCurrentQuarterInstant_jpcrp040300-q1r_E00752-000OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember－JPY
Equity IFRSCurrentQuarterInstant_EquityAttributableToOwnersOfParentIFRSMember1224801000000JPY
Equity IFRSCurrentQuarterInstant_NonControllingInterestsIFRSMember325138000000JPY
Equity IFRSCurrentQuarterInstant1549939000000JPY
Profit loss before tax IFRSPrior1YTDDuration113656000000JPY
Profit loss before tax IFRSCurrentYTDDuration-49862000000JPY
Depreciation and amortization ope cf IFRSPrior1YTDDuration43713000000JPY
Depreciation and amortization ope cf IFRSCurrentYTDDuration39300000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSPrior1YTDDuration-12671000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSCurrentYTDDuration12042000000JPY
Interest and dividend income ope cf IFRSPrior1YTDDuration-4321000000JPY
Interest and dividend income ope cf IFRSCurrentYTDDuration-5581000000JPY
Interest expenses ope cf IFRSPrior1YTDDuration5733000000JPY
Interest expenses ope cf IFRSCurrentYTDDuration6784000000JPY
Business structure improvement expenses ope cf IFRSPrior1YTDDuration2135000000JPY
Business structure improvement expenses ope cf IFRSCurrentYTDDuration19297000000JPY
Loss gain on sale of fixed assets ope cf IFRSPrior1YTDDuration-1896000000JPY
Loss gain on sale of fixed assets ope cf IFRSCurrentYTDDuration-725000000JPY
Decrease increase in trade receivables ope cf IFRSPrior1YTDDuration28174000000JPY
Decrease increase in trade receivables ope cf IFRSCurrentYTDDuration53451000000JPY
Decrease increase in inventories ope cf IFRSPrior1YTDDuration-57141000000JPY
Decrease increase in inventories ope cf IFRSCurrentYTDDuration-34127000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass